| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 88325 |
|
15,014 |
10,188 |
$890K |
| U0004 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r |
11,459 |
8,801 |
$460K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
10,000 |
7,763 |
$318K |
| 88305 |
Level IV - Surgical pathology, gross and microscopic examination |
7,346 |
6,301 |
$140K |
| G2023 |
Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
10,671 |
8,170 |
$113K |
| 88361 |
|
1,513 |
1,027 |
$109K |
| U0005 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 |
9,512 |
7,318 |
$92K |
| 88307 |
|
2,199 |
1,882 |
$45K |
| 88312 |
|
1,201 |
1,065 |
$27K |
| 88300 |
|
5,973 |
5,868 |
$11K |
| 87811 |
Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) |
33 |
26 |
$1K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
20 |
17 |
$945.96 |